Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh J Field

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Virological Methods|March 7, 2002
Temporal pattern of herpes simplex virus type 1 infection and cell death in the mouse brain stem: influence of guanosine nucleoside analoguesMargaret M Shaw, Werner K Gürr, Alana M Thackray, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2008
A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral targetSubhajit Biswas, Gerald Kleymann, Mihaiela Swift, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection modelSubhajit Biswas, Soumi Sukla, Thomas Goldner, et al.
Antiviral Chemistry & Chemotherapy|October 30, 2003
ME-609: a treatment for recurrent herpes simplex virus infectionsJohan G Harmenberg, Aftab R Awan, Stefan Alenius, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Virological Methods|March 7, 2002
Temporal pattern of herpes simplex virus type 1 infection and cell death in the mouse brain stem: influence of guanosine nucleoside analoguesMargaret M Shaw, Werner K Gürr, Alana M Thackray, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2008
A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral targetSubhajit Biswas, Gerald Kleymann, Mihaiela Swift, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection modelSubhajit Biswas, Soumi Sukla, Thomas Goldner, et al.
Antiviral Chemistry & Chemotherapy|October 30, 2003
ME-609: a treatment for recurrent herpes simplex virus infectionsJohan G Harmenberg, Aftab R Awan, Stefan Alenius, et al.
Pageof 4